OneBac: Platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy

Human Gene Therapy

Volumn 25, Issue 3, 2014, Pages 212-222

  Mietzsch, Mario ^a   Grasse, Sabrina ^a   Zurawski, Catherine ^a   Weger, Stefan ^a   Bennett, Antonette ^b   Agbandje Mckenna, Mavis ^b   Muzyczka, Nicholas ^b   Zolotukhin, Sergei ^b   Heilbronn, Regine ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 1; ADENO ASSOCIATED VIRUS 10; ADENO ASSOCIATED VIRUS 11; ADENO ASSOCIATED VIRUS 12; ADENO ASSOCIATED VIRUS 2; ADENO ASSOCIATED VIRUS 3; ADENO ASSOCIATED VIRUS 4; ADENO ASSOCIATED VIRUS 5; ADENO ASSOCIATED VIRUS 6; ADENO ASSOCIATED VIRUS 7; ADENO ASSOCIATED VIRUS 8; ADENO ASSOCIATED VIRUS 9; ANIMAL CELL; ARTICLE; BACULOVIRUS; CAP GENE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INSECT CELL; NONHUMAN; REP GENE; SCALE UP; SEROTYPE; VIRAL GENE THERAPY; VIRUS GENE; VIRUS GENOME; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS STRAIN;

ANIMALS; BACULOVIRIDAE; CELL LINE; DEPENDOVIRUS; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HEK293 CELLS; HELA CELLS; HELPER VIRUSES; HUMANS; TRANSDUCTION, GENETIC; TRANSFECTION; VIRAL PROTEINS;

EID: 84896368264     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2013.184     Document Type: Article

References (43)

1. Aslanidi, G., Lamb, K., and Zolotukhin, S. (2009). An inducible system for highly efficient production of recombinant adeno-associated virus (rAAV) vectors in insect Sf9 cells. Proc. Natl. Acad. Sci. USA 106, 5059-5064.
2. Becerra, S.P., Koczot, F., Fabisch, P., et al. (1988). Synthesis of adeno-associated virus structural proteins requires both alternative mRNA splicing and alternative initiations from a single transcript. J. Virol. 62, 2745-2754.
3. Berger, I., Fitzgerald, D.J., and Richmond, T.J. (2004). Bacu-lovirus expression system for heterologous multiprotein complexes. Nat. Biotechnol. 22, 1583-1587.
4. Cecchini, S., Virag, T., and Kotin, R.M. (2011). Reproducible high yields of recombinant adeno-associated virus produced using invertebrate cells in 0.02-to 200-liter cultures. Hum. Gene Ther. 22, 1021-1030.
5. Chadeuf, G., Ciron, C., Moullier, P., et al. (2005). Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery. Mol. Ther. 12, 744-753.
6. Chen, H. (2008). Intron splicing-mediated expression of AAV Rep and Cap genes and production of AAV vectors in insect cells. Mol. Ther. 16, 924-930.
7. Chen, H. (2012). Exploiting the intron-splicing mechanism of insect cells to produce viral vectors harboring toxic genes for suicide gene therapy. Mol. Ther. Nucleic Acids 1, e57.
8. Clark, K.R., Voulgaropoulou, F., and Johnson, P.R. (1996). A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors. Gene Ther. 3, 1124-1132.
9. Clement, N., Knop, D.R., and Byrne, B.J. (2009). Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufacturing for clinical studies. Hum. Gene Ther. 20, 796-806.
10. Conway, J., Rhys, C., Zolotukhin, I., et al. (1999). High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 rep and cap. Gene Ther. 6, 986-993.
11. Excoffon, K.J., Koerber, J.T., Dickey, D.D., et al. (2009). Directed evolution of adeno-associated virus to an infectious respiratory virus. Proc. Natl. Acad. Sci. USA 106, 3865-3870.
12. Galibert, L., and Merten, O.W. (2011). Latest developments in the large-scale production of adeno-associated virus vectors in insect cells toward the treatment of neuromuscular diseases. J. Invertebr. Pathol. 107 Suppl, S80-S93.
13. Gao, G.P., Alvira, M.R., Wang, L., et al. (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 99, 11854-11859.
14. Gao, G., Alvira, M.R., Somanathan, S., et al. (2003). Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc. Natl. Acad. Sci. USA 100, 6081-6086.
15. Grimm, D., Kern, A., Rittner, K., et al. (1998). Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum. Gene Ther. 9, 2745-2760.
16. Grimm, D., Kay, M.A., and Kleinschmidt, J.A. (2003). Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol. Ther. 7, 839-850.
17. Heilbronn, R., Engstler, M., Weger, S., et al. (2003). ssDNA-dependent colocalization of adeno-associated virus Rep and herpes simplex virus ICP8 in nuclear replication domains. Nucleic Acids Res. 31, 6206-6213.
18. Hüser, D., Weger, S., and Heilbronn, R. (2003). Packaging of human chromosome 19-specific adeno-associated virus (AAV) integration sites in AAV virions during AAV wild-type and recombinant AAV vector production. J. Virol. 77, 4881-4887.
19. Kang, W., Wang, L., Harrell, H., et al. (2008). An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes. Gene Ther. 16, 229-239.
20. Kastelein, J.J., Ross, C.J., and Hayden, M.R. (2013). From mutation identification to therapy: discovery and origins of the first approved gene therapy in the Western world. Hum. Gene Ther. 24, 472-478.
21. Kohlbrenner, E., Aslanidi, G., Nash, K., et al. (2005). Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system. Mol. Ther. 12, 1217-1225.
22. Kuck, D., Kern, A., and Kleinschmidt, J.A. (2007). Development of AAV serotype-specific ELISAs using novel monoclonal antibodies. J. Virol. Methods 140, 17-24.
23. Lock, M., Alvira, M., Vandenberghe, L.H., et al. (2010). Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale. Hum. Gene Ther. 21, 1259-1271.
24. Martin, J., Frederick, A., Luo, Y., et al. (2013). Generation and characterization of adeno-associated virus producer cell lines for research and preclinical vector production. Hum. Gene Ther. Methods 24, 253-269.
25. Mingozzi, F., and High, K.A. (2011). Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat. Rev. Genet. 12, 341-355.
26. Mitchell, M., Nam, H.J., Carter, A., et al. (2009). Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 9. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 65, 715-718.
27. Mori, S., Wang, L., Takeuchi, T., et al. (2004). Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein. Virology 330, 375-383.
28. Nathwani, A.C., Tuddenham, E.G., Rangarajan, S., et al. (2011). Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N. Engl. J. Med. 365, 2357-2365.
29. Nony, P., Chadeuf, G., Tessier, J., et al. (2003). Evidence for packaging of rep-cap sequences into adeno-associated virus (AAV) type 2 capsids in the absence of inverted terminal repeats: a model for generation of rep-positive AAV particles. J. Virol. 77, 776-781.
30. Schmidt, M., Voutetakis, A., Afione, S., et al. (2008). Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid-and heparan sulfate proteoglycan-independent transduction activity. J. Virol. 82, 1399-1406.
31. Smith, R.H., Levy, J.R., and Kotin, R.M. (2009). A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells. Mol. Ther. 17, 1888-1896.
32. Sonntag, F., Bleker, S., Leuchs, B., et al. (2006). Adeno-asso-ciated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus. J. Virol. 80, 11040-11054.
33. Sonntag, F., Schmidt, K., and Kleinschmidt, J.A. (2010). A viral assembly factor promotes AAV2 capsid formation in the nucleolus. Proc. Natl. Acad. Sci. USA 107, 10220-10225.
34. Sonntag, F., Kother, K., Schmidt, K., et al. (2011). The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes. J. Virol. 85, 12686-12697.
35. Thomas, D.L., Wang, L., Niamke, J., et al. (2009). Scalable recombinant adeno-associated virus production using re-combinant herpes simplex virus type 1 coinfection of suspension-adapted mammalian cells. Hum. Gene Ther. 20, 861-870.
36. Urabe, M., Ding, C., and Kotin, R.M. (2002). Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum. Gene Ther. 13, 1935-1943.
37. Urabe, M., Nakakura, T., Xin, K.Q., et al. (2006). Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells. J. Virol. 80, 1874-1885.
38. Virag, T., Cecchini, S., and Kotin, R.M. (2009). Producing re-combinant adeno-associated virus in foster cells: overcoming production limitations using a baculovirus-insect cell expression strategy. Hum. Gene Ther. 20, 807-817.
39. Winter, K., von Kietzell, K., Heilbronn, R., et al. (2012). Roles of E4orf6 and VA I RNA in adenovirus-mediated stimulation of human parvovirus B19 DNA replication and structural gene expression. J. Virol. 86, 5099-5109.
40. Wistuba, A., Weger, S., Kern, A., et al. (1995). Intermediates of adeno-associated virus type 2 assembly: identification of soluble complexes containing Rep and Cap proteins. J. Virol. 69, 5311-5319.
41. Wistuba, A., Kern, A., Weger, S., et al. (1997). Subcellular compartmentalization of adeno-associated virus type 2 assembly. J. Virol. 71, 1341-1352.
42. Xiao, X., Li, J., and Samulski, R.J. (1998). Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72, 2224-2232.
43. Zolotukhin, S. (2005). Production of recombinant adeno-associated virus vectors. Hum. Gene Ther. 16, 551-557.